Clarity Pharmaceuticals Ltd has released a press release.
First patient treated in the prostate cancer imaging trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Clarity Pharmaceuticals Ltd. on 6ix
Earlier from Clarity Pharmaceuticals
- Clarity Half Yearly Report
- Half Year Accounts
- Update on China Grand Pharmaceutical and Healthcare Holdings
- First patient treated in cohort 2 neuroblastoma trial
- US FDA Study May Proceed letter for Cu-64 SAR-bisPSMA
Later from Clarity Pharmaceuticals
- Presentation Jefferies Biotech Summit
- Notification regarding unquoted securities - CU6
- IND Approval by US FDA for Phase II SAR-Bombesin trial
- Governance & Trading Policy Update
- Application for quotation of securities - CU6
Follow Clarity Pharmaceuticals into a list and get an email when it puts out news.
Follow Clarity Pharmaceuticals